Angelina Mosiagina

Dr. Angelina Mosiagina

Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenetsky
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ASAlla Salmina
Alla Salmina
EKEkaterina V. Kharitonova
Ekaterina V. Kharitonova
YGYana V. Gorina
Yana V. Gorina
ETElena A. Teplyashina
Elena A. Teplyashina
NMNatalia A. Malinovskaya
Natalia A. Malinovskaya
YKYulia Komleva
Yulia Komleva
Pathophysiology of chronic neurodegeneration is mainly based on complex mechanisms related to aberrant signal transduction, excitation/inhibition imbalance, excitotoxicity, synaptic dysfunction, oxidative stress, proteotoxicity and protein misfolding, local insulin resistance and metabolic dysfunction, excessive cell death, development of glia-supported neuroinflammation, and failure of neurogenesis. These mechanisms tightly associate with dramatic alterations in the structure and activity of the neurovascular unit (NVU) and the blood–brain barrier (BBB). NVU is an ensemble of brain cells (brain microvessel endothelial cells (BMECs), astrocytes, pericytes, neurons, and microglia) serving for the adjustment of cell-to-cell interactions, metabolic coupling, local microcirculation, and neuronal excitability to the actual needs of the brain. The part of the NVU known as a BBB controls selective access of endogenous and exogenous molecules to the brain tissue and efflux of metabolites to the blood, thereby providing maintenance of brain chemical homeostasis critical for efficient signal transduction and brain plasticity. In Alzheimer’s disease, mitochondria are the target organelles for amyloid-induced neurodegeneration and alterations in NVU metabolic coupling or BBB breakdown. In this review we discuss understandings on mitochondria-driven NVU and BBB dysfunction, and how it might be studied in current and prospective NVU/BBB in vitro models for finding new approaches for the efficient pharmacotherapy of Alzheimer’s disease.

Verified
Journal Article
Open access
PDF file
EKElena Khilazheva
Elena Khilazheva
Angelina MosiaginaAngelina Mosiagina
Angelina Mosiagina
YPYulia A. Panina
Yulia A. Panina
OBOlga Belozor
Olga Belozor
YKYulia Komleva
Yulia Komleva
Immunosenescence and chronic inflammation associated with old age accompany brain aging and the loss of complex behaviors. Neuroinflammation in the hippocampus plays a pivotal role in the development of cognitive impairment and anxiety. However, the underlying mechanisms have not been fully explained. In this study, we aimed to investigate the disruption of insulin signaling and the mechanisms underlying metabolic inflammation (“metaflammation”) in the brains of wild-type (WT) and NLRP3 knockout (KO) mice of different ages. We found a significant upregulation of the NLRP3 inflammasome in the hippocampus during aging, leading to an increase in the expression of phosphorylated metaflammation proteinases and inflammatory markers, along with an increase in the number of senescent cells. Additionally, metaflammation causes anxiety and impairs social preference behavior in aged mice. On the other hand, deletion of NLRP3 improves some behavioral and biochemical characteristics associated with aging, such as signal memory, neuroinflammation, and metabolic inflammation, but not anxious behavior. These results are associated with reduced IL-18 signaling and the PKR/IKKβ/IRS1 pathway as well as the SASP phenotype. In NLRP3 gene deletion conditions, PKR is down-regulated. Therefore, it is likely that slowing aging through various NLRP3 inhibition mechanisms will lessen the corresponding cognitive decline with aging. Thus, the genetic knockout of the NLRP3 inflammasome can be seen as a new therapeutic strategy for slowing down central nervous system (CNS) aging.

20 July 2022 in Cells
Verified
Journal Article
Open access
PDF file
ASAnton Shuvaev
Anton Shuvaev
OBOlga Belozor
Olga Belozor
OMOleg Mozhei
Oleg Mozhei
ASAnton Shuvaev
Anton Shuvaev
YFYana V. Fritsler
Yana V. Fritsler
Sergey KasparovSergey Kasparov
Sergey Kasparov
Spinocerebellar ataxia type 1 (SCA1) is an intractable progressive neurodegenerative disease that leads to a range of movement and motor defects and is eventually lethal. Purkinje cells (PC) are typically the first to show signs of degeneration. SCA1 is caused by an expansion of the polyglutamine tract in the ATXN1 gene and the subsequent buildup of mutant Ataxin-1 protein. In addition to its toxicity, mutant Ataxin-1 protein interferes with gene expression and signal transduction in cells. Recently, it is evident that ATXN1 is not only expressed in neurons but also in glia, however, it is unclear the extent to which either contributes to the overall pathology of SCA1. There are various ways to model SCA1 in mice. Here, functional deficits at cerebellar synapses were investigated in two mouse models of SCA1 in which mutant ATXN1 is either nonspecifically expressed in all cell types of the cerebellum (SCA1 knock-in (KI)), or specifically in Bergmann glia with lentiviral vectors expressing mutant ATXN1 under the control of the astrocyte-specific GFAP promoter. We report impairment of motor performance in both SCA1 models. In both cases, prominent signs of astrocytosis were found using immunohistochemistry. Electrophysiological experiments revealed alteration of presynaptic plasticity at synapses between parallel fibers and PCs, and climbing fibers and PCs in SCA1 KI mice, which is not observed in animals expressing mutant ATXN1 solely in Bergmann glia. In contrast, short- and long-term synaptic plasticity was affected in both SCA1 KI mice and glia-targeted SCA1 mice. Thus, non-neuronal mechanisms may underlie some aspects of SCA1 pathology in the cerebellum. By combining the outcomes of our current work with our previous data from the B05 SCA1 model, we further our understanding of the mechanisms of SCA1.

1 January 2021 in Biomeditsinskaya Khimiya
Verified
Journal Article
Closed access
PDF file
EKE.D. Khilazheva
E.D. Khilazheva
AMA.V. Morgun
A.V. Morgun
EBE.B. Boytsova
E.B. Boytsova
Angelina MosiaginaAngelina Mosiagina
Angelina Mosiagina
ASA.N. Shuvaev
A.N. Shuvaev
ASA.B. Salmina
A.B. Salmina
In the central nervous system of mammals, there are specialized areas in which neurogenesis - neurogenic niches - is observed in the postnatal period. It is believed that astrocytes in the composition of neurogenic niches play a significant role in the regulation of neurogenesis, and therefore they are considered as a promising "target" for the possible control of neurogenesis, including the use of optogenetics. In the framework of this work, we formed an in vitro model of a neurogenic niche, consisting of cerebral endothelial cells, astrocytes and neurospheres. Astrocytes in the neurogenic niche model expressed canalorodopsin ChR2 and underwent photoactivation. The effect of photoactivated astrocytes on the expression profile of neurogenic niche cells was evaluated using immunocytochemical analysis methods. It was found that intact astrocytes in the composition of the neurogenic niche contribute to neuronal differentiation of stem cells, as well as the activation of astroglia expressing photosensitive proteins, changes the expression of molecules characterized by intercellular interactions of pools of resting and proliferating cells in the composition of the neurogenic niche with the participation of NAD+ (Cx43, CD38, CD157), lactate (MCT1). In particular, the registered changes reflect a violation of the paracrine intercellular interactions of two subpopulations of cells, one of which acts as a source of NAD+, and the second as a consumer of NAD+ to ensure the processes of intracellular signal transduction; a change in the mechanisms of lactate transport due to aberrant expression of the lactate transporter MCT1 in cells forming a pool of cells developing along the neuronal path of differentiation. In general, with photostimulation of niche astrocytes, the total proliferative activity increases mainly due to neural progenitor cells, but not neural stem cells. Thus, optogenetic activation of astrocytes can become a promising tool for controlling the activity of neurogenesis processes and the formation of a local proneurogenic microenvironment in an in vitro model of a neurogenic niche.

25 September 2021 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
Angelina MosiaginaAngelina Mosiagina
Angelina Mosiagina
AMAndrey Morgun
Andrey Morgun
ASAlla Salmina
Alla Salmina
There is growing research focusing on endothelial cells as separate units of the blood-brain barrier (BBB), and on the complex relationships between different types of cells within a neurovascular unit. To conduct this type of studies, researches use vastly different in vitro BBB models. The main objective of such models is to study the BBB permeability for different molecules, and to advance the current level of understanding the mechanisms of disease and to develop methods of targeted therapy for the central nervous system. The analysis of the existing Abstract in vitro BBB models and their advantages/disadvantages was conducted using the clinical trial data obtained in Russian/foreign countries. In this review, the authors highlight the most relevant assessment parameters and propose a unified classification of in vitro BBB models. According to the performed analysis, there is a tendency to move from 2D BBB models based on semipermeable inserts to 3D BBB spheroid and microfluidic organ-on-chip models. Moreover, the use of human induced pluripotent stem cells instead of animal primary cells will make it possible to reliably scale the results obtained in vitro to conditions in vivo.

4 August 2023 in Cell and Tissue Biology
Verified
Journal Article
Closed access
PDF file
Angelina MosiaginaAngelina Mosiagina
Angelina Mosiagina
EKE. D. Khilazheva
E. D. Khilazheva
AMA. V. Morgun
A. V. Morgun
This study aimed to demonstrate the advantage of a four-cell model of the blood–brain barrier (BBB) in vitro in comparison with the traditional three-cell model, as well as the influence of pericytes on the phenotype of endothelial cells. This paper describes a method for co-culture of primary brain microvascular endothelial cells, pericytes, astrocytes, and neurons in the Transwell BBB model in vitro. A quantitative analysis was carried out between the values of transendothelial electrical resistance (TEER), as well as between the content of endothelial cell tight junction markers in three- and four-cell Transwell models of the BBB. According to the obtained data, the presence of pericytes is accompanied by higher TEER values and a higher content of tight junction proteins. The presented results are consistent with the world scientific literature and confirm the hypothesis that pericytes not only perform a supporting function for endothelial cells, but are also an important metabolic link that regulates the barrier functions of the BBB. Thus, co-culture of cells of the neurovascular unit (NVU) of the brain with pericytes is necessary for the formation of a phenotype in endothelial cells that is close to the conditions in the NVU microenvironment in vivo.